Sign in
8-K

Current Report

Denali Therapeutics Inc. Filed Acc 0001193125-22-077264

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d310285d8k.htm…